Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy

Zakile A. Mfumbilwa, Martijn J.H.G. Simons, Bram Ramaekers, Valesca P. Retèl, Joanne M. Mankor, Harry J.M. Groen, Joachim G.J.V. Aerts, Manuela Joore, Janneke A. Wilschut, Veerle M.H. Coupé*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
24 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Material Science